Significant bleeding risk may outweigh any benefit
Amount of HDL may be less important than previously thought
A closer look at extended antiplatelet therapy
Further lowering LDL reduces risk in post-ACS patients
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Exposure can be lowered without affecting test results
20 years, 50 key developments
Veteran surgeon will lead nation’s top cardiac program
Despite DES, restenosis remains a risk
Techniques help provide a complete picture of the coronary tree
Remote endarterectomy avoids third bypass operation
Advertisement
Advertisement